MLM Biologics, Inc.
MLM Biologics Inc. is a company dedicated to advancing wound care solutions through innovative collagen-based products. They focus on delivering evidence-based, economical, and effective wound closure options, including their flagship product bio-ConneKt® Wound Matrix, which is FDA-cleared and produced in ISO-certified facilities. The company's mission is to provide more for less for many, emphasizing wound closure over mere management, and they are involved in ongoing research and development to improve wound care and other musculoskeletal treatments.
Industries
Nr. of Employees
small (1-50)
MLM Biologics, Inc.
606 SW 3rd Avenue, Gainesville, FL 32601
Products
Stabilized Type I collagen wound matrix (sterile, dry)
An all-biologic, reconstituted Type I collagen dressing manufactured sterile and supplied dry for room-temperature storage; designed to conform to wound beds, enable host cell infiltration, absorb exudate, and support remodeling and wound closure.
Stabilized Type I collagen wound matrix (sterile, dry)
An all-biologic, reconstituted Type I collagen dressing manufactured sterile and supplied dry for room-temperature storage; designed to conform to wound beds, enable host cell infiltration, absorb exudate, and support remodeling and wound closure.
Services
Production of terminally sterile, room-temperature stable collagen matrices in an ISO 13485 certified facility.
Assistance with regulatory clearances, product-specific coding (HCPCS) and Medicare Part B reimbursement processes, and liaison to reimbursement partners.
Surgeon training, clinical presentations, case documentation, and 24/7 technical/administrative assistance for product use.
Formation of exclusive distribution agreements and partnerships to handle sales, marketing, and reimbursement assistance in defined territories.
Production of terminally sterile, room-temperature stable collagen matrices in an ISO 13485 certified facility.
Assistance with regulatory clearances, product-specific coding (HCPCS) and Medicare Part B reimbursement processes, and liaison to reimbursement partners.
Surgeon training, clinical presentations, case documentation, and 24/7 technical/administrative assistance for product use.
Formation of exclusive distribution agreements and partnerships to handle sales, marketing, and reimbursement assistance in defined territories.
Expertise Areas
- Wound closure and advanced wound care
- Collagen-based biomaterials
- Medical device manufacturing (ISO 13485)
- Regulatory compliance and reimbursement (FDA 510(k), HCPCS, Medicare)
Key Technologies
- Type I collagen scaffold
- Collagen stabilization chemistry
- Porous hydrophilic scaffold design
- Terminal sterilization (SAL 10^-6)
News & Updates
On December 1st, 2023, it was announced that BioWound Solutions has acquired the exclusive sales and marketing rights to MLM Biologic’s bio-Connekt® Wound Matrix in the U.S.
In 2023, MLM Biologics was awarded almost $1.5 million by USAMRDC to develop a device for battlefield wound infection prevention.
MLM Biologics received ISO 13485 Certification in 2015, ensuring quality manufacturing standards.
MLM Biologics received FDA 510(k) clearance in 2014 for bio-ConneKt® Wound Matrix.
On December 1st, 2023, it was announced that BioWound Solutions has acquired the exclusive sales and marketing rights to MLM Biologic’s bio-Connekt® Wound Matrix in the U.S.
In 2023, MLM Biologics was awarded almost $1.5 million by USAMRDC to develop a device for battlefield wound infection prevention.
MLM Biologics received ISO 13485 Certification in 2015, ensuring quality manufacturing standards.
MLM Biologics received FDA 510(k) clearance in 2014 for bio-ConneKt® Wound Matrix.